CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Ginkgo Enters Into A Definitive Agreement To Acquire Zymergen

Ginkgo Enters Into A Definitive...

Three Problems Faced By Biotech Companies

Three Problems Faced By Biotech...

The Value of New Antibiotics in the Fight Against AMR

The Value of New Antibiotics in the...

Improving Minimal Residual Disease Detection Using NGS

Improving Minimal Residual Disease...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

Ginkgo Enters Into A Definitive Agreement To Acquire Zymergen

Ginkgo Enters Into A Definitive...

Three Problems Faced By Biotech Companies

Three Problems Faced By Biotech...

The Value of New Antibiotics in the Fight Against AMR

The Value of New Antibiotics in the...

Improving Minimal Residual Disease Detection Using NGS

Improving Minimal Residual Disease...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

Exocel Bio Ushers In The Next Generation Of Regenerative Aesthetics With All-Natural Exosomes Serum, Exovextm

Life Sciences Review Life Sciences Review | Wednesday, June 01, 2022
Tweet

Fremont, CA: Exovex, an all-natural serum of high quality, high concentration, non-lyophilized, and purified exosomes formulated to accelerate recovery time, reduce inflammation, and enhance the results of aesthetic medical treatments, is being revolutionized by ExoCel Bio, a biotechnology company focused on the research and development of cell-based technology. Exovex, when used after energy-based treatments or micro-needling, activates the body's cellular repair, improving the appearance of fine lines, wrinkles, skin tone, and texture.


ExoCel Bio exosomes are created by mesenchymal stem cells isolated and grown from the chorion layer of a healthy, donated human placenta that has already been tested for communicable illnesses and infections. The recipe was created by the company's scientific team during a two-year period of rigorous product curation to generate the safest and most potent exosome serum currently available on the market.


 Exovex exosomes include thousands of bioactive compounds, such as peptide growth factors and mRNA that code for collagen, keratin, elastin, and other anti-aging and anti-inflammatory proteins. ExovexTM contains 10 to 100 times the number of growth factors found in Platelet Rich Plasma (PRP).


ExovexTM is available in four non-lyophilized active exosome concentrations ranging from 5-100 billion per vial and is intended to accompany various cosmetic procedures like facials, micro-needling, and energy-based devices. ExoCel Bio products get rigorously evaluated using modern techniques such as NGS, MUDPit, and a nine-step patent-pending screening methodology to provide the safest nanoparticle acellular products available. This painstaking approach ensures that Exovex is the world's most thoroughly vetted and effective exosomes.


Weekly Brief

loading
Top 10 Biotech Companies in Latin America - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/exocel-bio-ushers-in-the-next-generation-of-regenerative-aesthetics-with-allnatural-exosomes-serum-exovextm-nwid-830.html